Preclinical CRO Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast 2032
The demand for specialized preclinical services,
particularly in fields like genomics, toxicology, and bioinformatics, is
driving the growth of the market. The global preclinical CRO market was
valued at USD 1.42 billion in 2022 and is expected to reach approximately USD
11.8 billion by 2032, growing at a CAGR of 7.6% during the forecast period of
2023–2032. Pharmaceutical and biotechnology companies are placing an increasing
emphasis on outsourcing to cut costs and expedite drug discovery processes.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/preclinical-cro-market
Pharmaceutical, biotechnology, and medical device companies
hire preclinical contract research organizations, or CROs, to conduct research
and testing during the preclinical stage of drug development. CROs provide a
wide range of services, such as pharmacology, toxicology, safety assessment,
efficacy studies, and bioanalytical testing, which aids in the evaluation of
the safety and pharmacokinetics of new drug candidates before moving them
forward to clinical trials. By outsourcing preclinical research to CROs,
pharmaceutical companies can expedite the drug development process while saving
money and gaining access to specialized knowledge and resources. In general,
CROs are essential in facilitating the translation of promising drug candidates
into clinical trials.
GROWTH DRIVERS
The increasing trend among biotechnology and pharmaceutical
companies to outsource preclinical research activities to CROs is largely due
to two factors: access to specialized expertise as they seek out external
partners with the infrastructure and expertise to conduct the preclinical
studies effectively, and cost reduction in the ongoing increase in global
research and development expenditure as companies invest more in R&D.
Strong pipeline biopharmaceutical goods with intricate therapies need specific
testing, such as toxicology, pharmacology, and safety evaluation, which CRO
provides.
The COVID-19 pandemic has brought to light the significance
of preclinical research in pandemic preparedness. To combat the virus,
pharmaceutical companies and government agencies have increased their
investment in preclinical studies aimed at finding effective treatments and
vaccines. CROs have been instrumental in supporting these efforts by providing
testing services and virology and immunology expertise. In general, as long as
public health threats are addressed globally, there will be a need for preclinical CRO services.
MARKET
SEGMENTATION:
· By
Service Type –
·
Bioanalysis
·
Toxicology
Testing
·
Compound
Management and Chemistry
·
Safety
Pharmacology and Others
· By
Model type –
·
Patient
Derived Organoid (PDO) Model
·
Patient
Derived Xenograft (PDX) Model
· By
End User –
·
Biopharmaceutical
Companies
·
Government
and Academics Institutes
·
Medical
Device Companies
· By
Region –
·
North
America
·
Europe
·
Asia
Pacific
·
Middle
East and Africa
·
South
America
Global Key
Players:
· Bioneeds
· Jubilant
Biosys
· TheraIndx
· Eurofins
· Wuxi
Apptec
· Medpace
· Charles
River Laboratories
· PPD
· SGA
SA
· Intertek
Group
For
More Information about this Report @ https://www.xresearch.biz/shop/preclinical-cro-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment